Hypertension, HFrEF + arrhythmias Flashcards
(22 cards)
Beta-1 antagonists for hypertension + what differentiates them
- atenolol (selective)
- propanolol (non-selective)
Atenolol MOA/adverse effects
- blocks B-1 receptors in heart thus preventing effect of increase HR, contractility etc.
- block effects of B-1 receptors at different respiratory, CNS, CV etc.
- postural hypotension
Propanolol MOA/adverse effects
- blocks B-1 + B-2 receptors at heart (more broad) to decrease HR + contractility + decrease hypertension
- block beta receptors in other places
cold extremities as vasodilation receptors blocked - postural hypotension
Calcium channel blockers for hypertension and their classes
- dihydropyridines
- Nifedipine
- non-dihydropyridines
- verapimil
- dilitazem
Nifedipine MOA/adverse effects
- blocks L type calcium channels in heart therefore blocking calcium current into cell thus decreasing Q, conduction, and increasing vasodilation of arteries
- dyspepsia
- bradycardia
Verapimil MOA/adverse effects
- blocks L type calcium channels into heart therefore blocking calcium current into cell thus decreasing Q, conduction, and increasing vasodilation of arteries
- dyspepsia
- bradycardia
Dilitazem MOA/adverse effects
- blocks L type calcium channels into heart therefore blocking calcium current into cell thus decreasing Q, conduction
ACE inhibitors for hypertension
perindopril
perindopril MOA/adverse effects
- binds to ACE enzyme + inhibits it therefore stopping conversion of angiotensin I to angiotensin II in RAAS cascade. Stops effectors so increases vasodilation + decreases symp. activity, ADH + aldosterone secretion
- hypotension, hyperkalemia
- increased bradykinin -> dry cough
Alpha-1 antagonist for hypertension
Prazosin
Prazosin MOA/adverse effects
- Inhibit a1 on vascular smooth muscle therefore causes vasodilation in veins + arteries -> decreases SVR + venous return to decrease BP
- postural hypotension
- lightheadedness
AT1 receptor antagonists/angiotension receptor blockers for hypertension
Sartans eg. candesartan
Candesartan MOA/adverse effects
- stop angiotensin II binding to AT1 receptor therefore causing vasodilation of blood vessels, decreased sympathetic activity, ADH + aldosterone secretion
Replacement of ACE inhibitor in HFrEF
Salcubitril (with valsartan)
Salcubitril + valsartan MOA/adverse effects
- inhibits neprilysin so causes vasodilation + increased GFR + bradykinin / decreases sympathetic tone + aldosterone release
Digoxin MOA/adverse effects
- inhibits Na/K/ATpase pump in myocardial cell therefore increases EF + Q
- arrhythmia, kidney issues
Ivabradine MOA/adverse effects
- inhibits a current regulating the interval b/t depolarisation of the SA node to decrease HR and therefore the cardiac workload of the heart
Potassium channel blockers for arrythmia’s
- Flecainide
- Sotalol
- Amiodarone
Flecainide MOA/adverse effects
- inhibits Na+ channels to slow automaticity of SA node
- bradycardia
Sotalol MOA/adverse effects
- blocks beta-receptors in SA + AV node to decrease automaticity + conduction velocity to prolong AP
- risk of torsades de pointes
Amiodarone MOA/adverse effects
- inhibit efflux of K+ to prolong repolarisation + increase refractory period therefore treats re-entry circuits
- phototoxicity, weight loss, anorexia